Chronic kidney disease: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
No edit summary
imported>Robert Badgett
m (Fixed link)
Line 8: Line 8:
*Stage 3 - [[glomerular filtration rate]] is 30-59 ml/min/1.73 m<sup>2</sup>
*Stage 3 - [[glomerular filtration rate]] is 30-59 ml/min/1.73 m<sup>2</sup>
*Stage 4 - [[glomerular filtration rate]] is 15-29 ml/min/1.73 m<sup>2</sup>
*Stage 4 - [[glomerular filtration rate]] is 15-29 ml/min/1.73 m<sup>2</sup>
*Stage 5 - [[glomerular filtration rate]] is less than 15 ml/min/1.73 m<sup>2</sup> or on [[dialysis]]
*Stage 5 - [[glomerular filtration rate]] is less than 15 ml/min/1.73 m<sup>2</sup> or on [[renal dialysis]]


==Etiology/cause==
==Etiology/cause==

Revision as of 05:15, 9 July 2008

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

Chronic kidney disease is defined as "kidney damage or glomerular filtration rate (GFR) <60 mL/min/1.73 m(2) for 3 months or more, irrespective of cause. Kidney damage in many kidney diseases can be ascertained by the presence of albuminuria, defined as albumin-to-creatinine ratio >30 mg/g in two of three spot urine specimens."[1]

Classification

There are five stages:[1]

Etiology/cause

Bilateral renal artery stenosis (RAS) may cause 5% to 15% of cases of chronic kidney disease.[2]

Signs and symptoms

Uremia, "the illness accompanying kidney failure", may have subtle manifestations when the glomerular filtration rate falls below 60 ml/min/1.73 m2 [3]

Treatment

Medications

Angiotensin inhibition

Angiotensin can be inhibited with either angiotensin converting enzyme inhibitors[4] or angiotensin II receptor antagonists. These medications can help patients with an elevated creatinine,[5] including those with a creatinine of 1.5 to 5.0 mg per deciliter.[6]

Phosphate binders

Phosphate binders (calcium carbonate 650 mg tabs three times per day by mouth and calcitriol 0.25-0.5 µg once per day) are given once a patient has Stage 3 disease in order to prevent secondary hyperparathyroidism.

References

  1. 1.0 1.1 Levey AS, Eckardt KU, Tsukamoto Y, et al (2005). "Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)". Kidney Int. 67 (6): 2089–100. DOI:10.1111/j.1523-1755.2005.00365.x. PMID 15882252. Research Blogging.
  2. Rimmer JM, Gennari FJ (May 1993). "Atherosclerotic renovascular disease and progressive renal failure". Ann. Intern. Med. 118 (9): 712–9. PMID 8460859[e]
  3. Meyer TW, Hostetter TH (2007). "Uremia". N. Engl. J. Med. 357 (13): 1316–25. DOI:10.1056/NEJMra071313. PMID 17898101. Research Blogging.
  4. Jafar TH, Stark PC, Schmid CH, et al (2003). "Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis". Ann. Intern. Med. 139 (4): 244–52. PMID 12965979[e]
  5. Ruggenenti P, Perna A, Remuzzi G (2001). "ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy". J. Am. Soc. Nephrol. 12 (12): 2832–7. PMID 11729254[e]
  6. Hou FF, Zhang X, Zhang GH, et al (2006). "Efficacy and safety of benazepril for advanced chronic renal insufficiency". N. Engl. J. Med. 354 (2): 131–40. DOI:10.1056/NEJMoa053107. PMID 16407508. Research Blogging.

External links